BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20007267)

  • 1. Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.
    Bayer W; Tenbusch M; Lietz R; Johrden L; Schimmer S; Uberla K; Dittmer U; Wildner O
    J Virol; 2010 Feb; 84(4):1967-76. PubMed ID: 20007267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection.
    Ohs I; Windmann S; Wildner O; Dittmer U; Bayer W
    PLoS One; 2013; 8(12):e82528. PubMed ID: 24349306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes.
    Bayer W; Lietz R; Ontikatze T; Johrden L; Tenbusch M; Nabi G; Schimmer S; Groitl P; Wolf H; Berry CM; Uberla K; Dittmer U; Wildner O
    Retrovirology; 2011 Sep; 8():75. PubMed ID: 21943056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies.
    Bayer W; Schimmer S; Hoffmann D; Dittmer U; Wildner O
    Vaccine; 2008 Jan; 26(5):716-26. PubMed ID: 18160188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.
    Bongard N; Le-Trilling VTK; Malyshkina A; Rückborn M; Wohlgemuth K; Wensing I; Windmann S; Dittmer U; Trilling M; Bayer W
    PLoS Pathog; 2019 Sep; 15(9):e1008043. PubMed ID: 31568492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.
    Kaulfuß M; Wensing I; Windmann S; Hrycak CP; Bayer W
    Retrovirology; 2017 Feb; 14(1):8. PubMed ID: 28166802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
    Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
    Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
    Hrycak CP; Windmann S; Bayer W
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of retroviral envelope with vaccine-induced CD8
    Bongard N; Lapuente D; Windmann S; Dittmer U; Tenbusch M; Bayer W
    Retrovirology; 2017 Apr; 14(1):28. PubMed ID: 28449719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses.
    Schlecht-Louf G; Renard M; Mangeney M; Letzelter C; Richaud A; Ducos B; Bouallaga I; Heidmann T
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3782-7. PubMed ID: 20142478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection.
    Lietz R; Bayer W; Ontikatze T; Johrden L; Tenbusch M; Storcksdieck Genannt Bonsmann M; Uberla K; Dittmer U; Wildner O
    J Virol; 2012 Feb; 86(3):1706-16. PubMed ID: 22090142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
    Sugahara D; Tsuji-Kawahara S; Miyazawa M
    J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
    Chmielewska AM; Naddeo M; Capone S; Ammendola V; Hu K; Meredith L; Verhoye L; Rychlowska M; Rappuoli R; Ulmer JB; Colloca S; Nicosia A; Cortese R; Leroux-Roels G; Balfe P; Bienkowska-Szewczyk K; Meuleman P; McKeating JA; Folgori A
    J Virol; 2014 May; 88(10):5502-10. PubMed ID: 24599994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge.
    Cox F; van der Fits L; Abbink P; Larocca RA; van Huizen E; Saeland E; Verhagen J; Peterson R; Tolboom J; Kaufmann B; Schuitemaker H; Barouch DH; Zahn R
    PLoS One; 2018; 13(8):e0202820. PubMed ID: 30142207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.
    Dittmer U; Brooks DM; Hasenkrug KJ
    J Virol; 1998 Aug; 72(8):6554-8. PubMed ID: 9658099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.
    Knuschke T; Rotan O; Bayer W; Sokolova V; Hansen W; Sparwasser T; Dittmer U; Epple M; Buer J; Westendorf AM
    Retrovirology; 2016 Apr; 13():24. PubMed ID: 27076190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells.
    Reuter T; Heldmann M; Schimmer S; Schepers K; Dittmer U
    Vaccine; 2004 Jul; 22(21-22):2686-9. PubMed ID: 15246598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for CD4(+) T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery mice.
    Super HJ; Brooks D; Hasenkrug K; Chesebro B
    J Virol; 1998 Nov; 72(11):9400-3. PubMed ID: 9765497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
    Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.